International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?

Stage III N2 nonsmall cell lung cancer (NSCLC) is a complex disease with poor treatment outcomes. For patients in whom the disease is considered technically resectable, the main treatment options include surgery (with neoadjuvant or adjuvant chemotherapy/neoadjuvant chemoradiotherapy (CRT)) or CRT f...

Descripción completa

Detalles Bibliográficos
Autores principales: Putora, Paul Martin, Leskow, Pawel, McDonald, Fiona, Batchelor, Tim, Evison, Matthiew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024765/
https://www.ncbi.nlm.nih.gov/pubmed/32083114
http://dx.doi.org/10.1183/23120541.00159-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024765/
https://www.ncbi.nlm.nih.gov/pubmed/32083114
http://dx.doi.org/10.1183/23120541.00159-2019

Ejemplares similares